Lamivudine Generics [uk]

Lamivudine, the active ingredient in Lamivudine Generics, is a nucleoside reverse transcriptase inhibitor (NRTI) presented as a tablet for oral use. It treats human immunodeficiency virus (HIV) infection and chronic hepatitis B infection in adults. GNH USA supplies Lamivudine Generics as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lamivudine is an antiretroviral nucleoside analogue used to manage viral infections that rely on reverse transcriptase. - Human immunodeficiency virus (HIV) infection: reduces viral load and helps restore immune function in infected individuals. - Chronic hepatitis B infection: suppresses viral replication and aids in preventing progression of liver disease.

Lamivudine may cause a range of adverse reactions, most of which are mild to moderate in severity.

Common Side Effects: - Nausea - Headache - Fatigue - Diarrhea - Insomnia - Dizziness

Serious or Rare Side Effects: - Lactic acidosis - Severe hepatotoxicity - Pancreatitis - Severe skin reactions (e.g., Stevens-Johnson syndrome) - Peripheral neuropathy - Hematologic abnormalities such as anemia or neutropenia

When prescribing lamivudine, clinicians should consider several safety aspects. - Renal impairment: assess kidney function and adjust dosing if necessary. - Hepatic impairment: monitor liver enzymes regularly. - Pregnancy: risk category unknown; discuss potential benefits and risks with the patient. - Concomitant medications: review for possible drug‑drug interactions. - Adherence: emphasize the importance of consistent daily intake. - Store at below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Lamivudine can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Didanosine: increased risk of pancreatitis. - Stavudine: heightened chance of peripheral neuropathy. - Ritonavir‑boosted protease inhibitors: may raise lamivudine plasma concentrations.

Moderate Interactions (Monitor Closely): - Tenofovir: additive renal toxicity; monitor kidney function. - Nevirapine: potential for altered hepatic enzyme activity. - Alcohol: may exacerbate liver toxicity. - Certain antacids: can affect absorption; advise spacing of doses. - Herbal supplements (e.g., St. John’s wort): may influence metabolic pathways.